ADVANCED DEVELOPMENT OF THE S-303 PATHOGEN INACTIVATION SYSTEM FOR RED BLOOD CELL COMPONENTS FOR TRANSFUSION AND WHOLE BLOOD

$2,098,000FY2011Department of DefenseDOD

Cerus Corporation, Concord CA

Investigators